Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma.

Neuro-oncology advances·2022
Same author

A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics.

Neuro-oncology·2022
Same author

"You can observe a lot by just watching" (Yogi Berra).

Neuro-oncology·2021
Same author

Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial.

The Lancet. Oncology·2021
Same author

Leptomeningeal metastases: how best to assess response.

Neuro-oncology·2020

Related Experiment Video

Updated: May 13, 2026

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

Brainstem glioma: a review.

Sean A Grimm1, Marc C Chamberlain

  • 1Department of Neurology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

Current Neurology and Neuroscience Reports
|March 21, 2013
PubMed
Summary
This summary is machine-generated.

Brainstem gliomas (BGs) are diverse pediatric brain tumors. Diffuse intrinsic pontine glioma (DIPG) is the most common and aggressive type, with limited treatment options and poor prognosis.

More Related Videos

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
09:18

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
12:25

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

Published on: January 7, 2014

Related Experiment Videos

Last Updated: May 13, 2026

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
09:18

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
12:25

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

Published on: January 7, 2014

Area of Science:

  • Neuro-oncology
  • Pediatric Oncology
  • Cancer Biology

Background:

  • Brainstem gliomas (BGs) represent a heterogeneous group of tumors predominantly affecting children.
  • Key subtypes include diffuse intrinsic pontine glioma (DIPG), exophytic medullary glioma, and tectal glioma.
  • DIPG is the most frequent BG, characterized by a median age of 6.5 years and survival under 1 year.

Purpose of the Study:

  • To review the classification, clinical presentation, and management of brainstem gliomas.
  • To highlight the differences in prognosis and biology between pediatric and adult DIPG.
  • To discuss emerging therapeutic targets and ongoing clinical trials.

Main Methods:

  • Review of existing literature on brainstem gliomas.
  • Analysis of clinical characteristics and outcomes for different BG subtypes.
  • Summary of current and investigational treatment strategies.

Main Results:

  • DIPG is the most common BG, with significantly poorer outcomes in children compared to adults.
  • Clinical presentation often involves cranial nerve deficits, long tract signs, or ataxia.
  • Standard treatment for DIPG is radiotherapy; targeted therapies for specific mutations are under investigation.
  • Exophytic medullary and tectal gliomas are generally indolent and may not require immediate treatment.

Conclusions:

  • Brainstem gliomas, particularly DIPG, present unique challenges in pediatric neuro-oncology.
  • Understanding tumor biology, including genetic mutations, is crucial for developing effective targeted therapies.
  • Further research and clinical trials are essential to improve outcomes for children with DIPG.